Advertisement

Inflammation

, Volume 12, Issue 5, pp 447–453 | Cite as

Variable effect of toxic shock toxins from different sources on neutrophil function in vitro

  • Elaine M. Berger
  • Gayle A. Shibao
  • Sally N. Brown
  • John E. Repine
Original Articles

Abstract

Toxic shock syndrome toxins (TSST) are 23–30 kD proteins that have been isolated from incubation media of strains ofStaphylococcus aureus cultured from patients with toxic shock syndrome (TSS). Injection of TSST into animals produces many of the symptoms that characterize TSS including shock, fever, and multiple organ failure. We found that addition of increasing concentrations of TSST-1-VP1035-16A, but not TSST-PEC, TSST-SEC, staphylococcal enterotoxin A or B, progressively decreased human neutrophil bactericidal activity againstS. aureus, 502A in vitro. TSST-1-VP1035-16A, but not the other toxins, also decreased superoxide anion and hydrogen peroxide concentrations in mixtures containing neutrophils and phorbol myristate acetate (PMA) in vitro. The results indicate that various preparations of TSST have different effects on neutrophil function in vitro and, accordingly, may have different effects in other in vitro and in vivo models of TSS.

Keywords

Incubation Medium Phorbol Variable Effect Multiple Organ Failure Human Neutrophil 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Davis, J. P., P. J. Chesney, P. J. Wand, M. Laventure, and the Investigation and Laboratory Team. 1980. Toxic-shock syndrome: Epidemiologic features, recurrence, risk factors, and prevention.N. Engl. J. Med. 303:1429–1435.Google Scholar
  2. 2.
    Shands, K. N., G. P. Schmid, B. B. Dan, D. Blum, R. J. Guidotti, N. T. Hargrett, R. L. Anderson, D. L. Hill, C. F. Broome, J. D. Band, andD. W. Fraser. 1980. Toxic shock syndrome in menstruating women: Association with tampon use andStaphylococcus aureus and clinical features in 52 cases.N. Engl. J. Med. 303:1436–1442.Google Scholar
  3. 3.
    Osterholm, M. T., J. P. Davis, R. W. Gibson, J. S. Mandell, L. A. Wintermeyer, C. M. Helms, J. C. Forfang, J. Rondeau, J. M. Vergeront, and the Investigation Team. 1982. Tri-state toxic shock syndrome. I. Epidemiologie findings.J. Infect. Dis. 145:431–440.Google Scholar
  4. 4.
    Follow-up on toxic shock syndrome. 1980.MMWR 29(37):441–445.Google Scholar
  5. 5.
    Reingold, A. L., B. B. Dan, K. N. Shands, andC. W. Broome. 1982. Toxic shock syndrome not associated with menstruation: A review of 54 cases.Lancet 1:1–4.Google Scholar
  6. 6.
    Bergdoll, M. S., B. A. Crass, R. F. Reiser, R. N. Robbins, andJ. P. Davis. 1981. A new staphylococcal enterotoxin, enterotoxin F, associated with toxic shock syndromeStaphylococcus aureus isolates.Lancet 1:1017–1021.Google Scholar
  7. 7.
    Todd, J., M. Fishaut, F. Kapral, andT. Welch. 1978. Toxic shock syndrome associated with phage-group-1 staphylococci.Lancet 2:1116–1118.Google Scholar
  8. 8.
    Schlievert, P. M., K. N. Shands, B. B. Dan, G. P. Schmid, andR. D. Nishimura. 1981. Identification and characterization of an exotoxin fromStaphylococcus aureus associated with toxic shock syndrome.J. Infect. Dis. 143:509–516.Google Scholar
  9. 9.
    Cohen, M. L., andS. Falkow. 1981. Protein antigens fromStaphylococcus aureus strains associated with toxic shock syndrome.Science 211:842–844.Google Scholar
  10. 10.
    Bonventre, P. F., L. Weckbach, J. Staneck, P. M. Schlievert andM. Thompson. 1983. Production of Staphylococcal enterotoxin F and pyrogenic exotoxin C byStaphylococcal aureus isolates from toxic shock syndrome-associated sources.Infect. Immun. 40(3):1023–1029.Google Scholar
  11. 11.
    Bergdoll, M. S., andP. M. Schlievert. 1984. Toxic shock syndrome toxin.Lancer 2:691 (letter).Google Scholar
  12. 12.
    Chesney, P. J., M. S. Bergdoll, J. P. Davis, andJ. M. Vergeront. 1984. The disease spectrum, epidemiology and etiology of toxic-shock syndrome,Annu. Rev. Microbiol. 38:315–338.Google Scholar
  13. 13.
    Goetz, M. B., R. A. Proctor, R. F. Reiser, andM. S. Bergdoll. 1983. Effect ofStaphylococcus aureus enterotoxin F on human neutrophil oxidative metabolism.J. Infect. Dis. 148(4):764.Google Scholar
  14. 14.
    Hjorth, R., A. K. Jonsson, andP. Vretblad. 1981. A rapid method for purification of human granulocytes using Percoll. A comparison with dextran sedimentation,J. Immunol. Methods 43:95–101.Google Scholar
  15. 15.
    Repine, J. E., andC. C. Clawson. 1977. Quantitative measurement of the bactericidal capability of neutrophils from patients and carriers of chronic granulomatous diseases.J. Lab. Clin. Med. 90:522–528.Google Scholar
  16. 16.
    Berger, E. M., R. N. Harada, A. E. Vatter, C. M. Bowman, andJ. E. Repine. 1984. Cyclical abnormalities in the bactericidal function, Superoxide production and lysozome activity of neutrophils obtained from a healthy woman during menstruation: Reversal by pretreatment with aspirin.J. Infect. Dis. 149:413–410.Google Scholar
  17. 17.
    Cassell, R. H., andI. Fridovich. 1975. The role of Superoxide radical in the autooxidation of cytochromec.Biochemistry 14(9):1866–1868.Google Scholar
  18. 18.
    Thurman, R. G., H. G. Ley, andR. Scholz. 1972. Hepatic microsomal ethanol oxidation: Hydrogen peroxide formation and the role of catalase.Eur. J. Biochem. 25:420–430.Google Scholar
  19. 19.
    Weiss, S. J., J. Young, A. F. Lobuglio, A. F. Slivka, andA. Slivka. 1981. Role of hydrogen peroxide in neutrophil-mediated destruction of cultured endothelial cells.J. Clin. Invest. 68:714–721.Google Scholar
  20. 20.
    Decker, L. A., editor. 1977. Worthington Enzyme Manual. Worthington Biochemical, Freehold, New Jersey. 185–188.Google Scholar
  21. 21.
    Quimby. F., andH. T. Nguyen. 1985. Animal studies of toxic shock syndrome.CRC Crit. Rev. Microbiol 12:1–44.Google Scholar
  22. 22.
    Kushnaryov, V. M., M. S. Bergdoll, H. S. MacDonald, J. Vellinga, andR. Reiser. 1984. Study of staphylococcal toxic shock syndrome toxin in human epithelial cell culture.J. Infect. Dis. 150(4):535–545.Google Scholar
  23. 23.
    Schlievert, P. M. 1983. Alteration of immune function by staphylococcal pyrogenic exotoxin type C: Possible role in toxic-shock syndrome.J. Infect. Dis. 147:391–398.Google Scholar
  24. 24.
    Schlievert, P. M. 1984. Biological properties of toxic shock syndrome exotoxin.Surv. Synth. Pathol. Res. 3:54–62.Google Scholar
  25. 25.
    Klebanoff, S. J., andR. A. Clark. 1978. Anti-microbial systems.In The Neutrophil: Function and Clinical Disorders. North Holland Publishing, New York. 409–488.Google Scholar
  26. 26.
    Repine, J. E. 1985. Neutrophils, oxygen radicals and the adult respiratory distress syndrome.In The Pulmonary Circulation and Acute Lung Injury. Futura Publishing, Mount Kisco, New York. 249–280.Google Scholar

Copyright information

© Plenum Publishing Corporation 1988

Authors and Affiliations

  • Elaine M. Berger
    • 1
  • Gayle A. Shibao
    • 1
  • Sally N. Brown
    • 1
  • John E. Repine
    • 1
  1. 1.Webb-Waring Lung Institute Departments of Medicine, Surgery, and PediatricsUniversity of Colorado Health Sciences CenterDenver

Personalised recommendations